Q&A: How 3PLs are navigating the latest pharma trends
Pharmaceutical third-party logistics (3PL) providers are moving beyond traditional warehousing into more holistic and strategic commercialization support. At the same …
Post
-
-
CVC consortium tables $12.4bn bid to delist Italian drugmaker Recordati
One of Italy’s only publicly traded large pharma companies could soon be taken into private ownership, after private equity firm …
-
Accelerate post-approval research by streamlining the entire study lifecycle
As oncology therapies mature, post-approval research is essential to supporting regulatory commitments, label expansion, and real-world adoption—often under tight timelines. …
-
European STI cases reach record high amid testing and prevention gaps
New data debuted by the Europe’s infectious disease agency has revealed that cases of certain bacterial sexually transmitted infections (STIs) …
-
Gilead Sciences completes Tubulis acquisition for $5bn
Gilead Sciences has concluded its acquisition of Tubulis, a Germany-based biotechnology company developing next-generation antibody-drug conjugates (ADCs), in a transaction …
-
Gilead Sciences completes Tubulis acquisition for $5bn
Gilead Sciences has concluded its acquisition of Tubulis, a Germany-based biotechnology company developing next-generation antibody-drug conjugates (ADCs), in a transaction …
-
Concept Life Sciences and OpenBench partner on drug discovery services
Concept Life Sciences has signed a strategic partnership with OpenBench to deliver success-based drug discovery services targeted at early-stage biotech …
-
Gilead teams up with WHO again to eliminate parasitic tropical disease
Gilead has pledged over 400,000 doses of its antifungal medication to countries affected by a parasitic tropical disease as part …
-
Eli Lilly maintains M&A streak with $202m Engage Bio buyout
Pharmaceutical giant Eli Lilly has agreed to acquire Engage Biologics for up to $202m in cash, marking another addition to …
-
FUJIFILM opens new iPSC facility in Madison, US
FUJIFILM Cellular Dynamics has opened a new headquarters and induced pluripotent stem cell (iPSC) manufacturing facility in Madison, Wisconsin, US. The …
-
Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends
With pharma and medtech Q1 earnings season now at a close, some sector areas performed better than others. In this episode, …
-
ATS 2026: PABPC4 gene identified as a key driver of emphysema in COPD
At the American Thoracic Society (ATS) 2026 annual meeting on 18 May, during the B109 cellular, genetics, and developmental drivers …
-
ATS 2026: Long-term data show durable benefit of Trikafta for cystic fibrosis
On 18 May, at the 2026 American Thoracic Society (ATS) international conference, during a poster session, a single-centre, observational cohort …
-
Quality by design: The impact of disconnected systems on clinical data
As clinical trials become more digitalised, the data landscape is expanding faster than the processes designed to control it. Electronic …
-
BMS and Anthropic collaborate for Claude implementation
Bristol Myers Squibb (BMS) has signed a strategic agreement with Anthropic to implement its Claude platform across its global operations. The …
